General Information of the Compound
Compound ID
CP0475306
Compound Name
4-[(2S)-2-(3-naphthalen-2-yl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]butan-1-ol
    Show/Hide
Structure
Formula
C21H25N3O2
Molecular Weight
351.45
Canonical SMILES
OCCCCN1CCCC[C@H]1c1nc(no1)-c1ccc2ccccc2c1
    Show/Hide
InChI
InChI=1S/C21H25N3O2/c25-14-6-5-13-24-12-4-3-9-19(24)21-22-20(23-26-21)18-11-10-16-7-1-2-8-17(16)15-18/h1-2,7-8,10-11,15,19,25H,3-6,9,12-14H2/t19-/m0/s1
    Show/Hide
InChIKey
DPYAMLRMBWSHCC-IBGZPJMESA-N
Physicochemical Property
logP
4.1893
Rotatable Bonds
6
Heavy Atom Count
26
Polar Areas
62.39
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
26

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 155541638
ChEMBL ID
CHEMBL4519624
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01286, Bile acid receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000063 Hep-G2 Homo sapiens (Human)  1
1
IC50 = 7000 nM
   TI
   LI
   LO
   TS